The Victorian state government has announced an agreement with the biopharmaceutical company Pfizer to increase “global collaboration opportunities with Victorian researchers and industry” on Mar. 18. Victoria’s minister for innovation and medical research, Jaala Pulford said that “this agreement with one of the world’s leading biopharmaceutical companies is a strong endorsement of the strength of Victoria’s research and development community and recognises our status as one of the world leaders in this field.” According to the Victorian government, experts from Pfizer’s Centers for Therapeutic Innovation (CTI) and RNA Accelerator will be working with mRNA Victoria—a government-funded mRNA organisation—to advance critical skills and connections with Victorian researchers and industry. “This initiative between mRNA Victoria and Pfizer will also deliver significant job opportunities for our state as leading biotech research and commercialisation is ramped up,” Pulford said on March 18. Established in 2010, Pfizer’s CTI is a joint drug discovery model focused …